News
Important Only
Aethlon Medical Inc reports results for the quarter ended June 30 - Earnings Summary
Aethlon Medical Inc AEMD.OQ reported a quarterly adjusted loss of 85 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-2.72. The mean expectation of three analysts for the quarter was for a loss of 86 cents per share. Wall St...Reuters
Wed, Aug 13
CMCT Leasing Surges as NOI Drops in Q2
Creative Media & Community Trust (NASDAQ:CMCT) reported fiscal Q2 2025 results on Aug. 12, 2025, highlighting a core funds from operations (FFO) loss of $7.2 million and a year-over-year increase of over 55% in leasing activity through July 2025. The call detailed progress on debt refinancing, multi...The Motley Fool
Wed, Aug 13
Longeveron Posts 32% Revenue Drop in Q2
Key PointsNet loss (GAAP) widened year over year for the six months ended Q2 2025, driven by sharply higher research and administrative expenses.Revenue (GAAP) fell 31.0% year-over-year for the six months ended Q2 2025, but came in above analyst estimates.Cash and cash equivalents (GAAP) were $10.33...The Motley Fool
Wed, Aug 13
Tenon Medical Revenue Falls 37 Percent
Tenon Medical(NASDAQ:TNON) reported results for the fiscal second quarter ended June 30, 2025, on August 6, 2025, emphasizing the completed CyVantage acquisition, a 29% year-over-year drop in operating expenses, and a 37.4% year-over-year revenue decline to $564,000. Management highlighted strategic...The Motley Fool
Wed, Aug 13
IceCure Medical Advances FDA Review
IceCure Medical(NASDAQ:ICCM) reported second-quarter 2025 results on Aug. 13, 2025, with revenue declining year-over-year to $1.25 million from $1.75 million for the six months ended June 30, 2025. The company highlighted regulatory progress for its ProSense system in breast cancer, a $10 million ri...The Motley Fool
Wed, Aug 13
Barfresh Q2 Revenue Up 11 Percent
Barfresh Food Group (NASDAQ:BRFH) reported second quarter 2025 results on August 13, 2025, highlighting 11% year-over-year revenue growth to $1.6 million (GAAP) in Q2 FY2025 and milestone achievements in manufacturing capacity. The company executed key strategic steps to address prior supply constra...The Motley Fool
Wed, Aug 13
Forian Revenue Jumps 56 Percent in Q2
Key PointsRevenue (GAAP) surged to $7.48 million in Q2 2025, up 56% year over year, beating analyst expectations, with GAAP revenue exceeding the analyst estimate of $7.17 million.With EPS (GAAP) of $0.01, meeting estimates.These 10 stocks could mint the next wave of millionaires › Forian (NASDAQ:FO...The Motley Fool
Wed, Aug 13
Aardvark Therapeutics Reports Q2 Loss
Key Points• Research and development expenses rose dramatically, resulting in a net loss per share of $(0.66) (GAAP), compared to an estimated $(0.60).• The HERO trial for ARD-101 (Prader-Willi Syndrome) expanded to include younger patients, and new Phase 2 trials for ARD-201 (obesity) were announce...The Motley Fool
Wed, Aug 13
GLOBAL MARKETS-World equities hit record highs, US yields fall on optimism for Fed rate cut
Benchmark S&P 500, Nasdaq hit record European shares gainOil prices drop, gold risesNikkei attains record high above 43,000Dollar index falls to two-week low By Chibuike Oguh NEW YORK, Aug 13 (Reuters) - An index of global equity markets rose to a record high for the second straight session o...Reuters
Wed, Aug 13
Red Robin Swings to Profit in Fiscal Q2
Key PointsEarnings per share (EPS) swung to a positive $0.26 (adjusted), beating the ($0.06) GAAP estimate and reversing a GAAP net loss from the prior year.Revenue (GAAP) of $283.7 million exceeded analyst expectations, reflecting lower guest traffic.The company lowered its full-year sales outlook ...The Motley Fool
Wed, Aug 13
Jade Biosciences Posts Wider Loss in Q2
Key PointsJade Biosciences reported a net loss per share of $0.86 (GAAP) for Q2 2025. The company missed analyst GAAP EPS estimates by $0.43, with the net loss per share widening significantly year over year.Research and development spending increased to $22.5 million as the company advanced its pre...The Motley Fool
Wed, Aug 13
Lantern Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Lantern Pharma Inc LTRN.OQ reported a quarterly adjusted loss of 40 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -46 cents. The mean expectation of two analysts for the quarter was for a loss of 48 cents per share. Wall St...Reuters
Wed, Aug 13
Forian Q2 Revenue Jumps 56 Percent
Forian (NASDAQ:FORA) reported second-quarter 2025 results on August 13, 2025, delivering GAAP revenue of $7.5 million, representing 56% year-over-year growth and net income (GAAP) of $224,000. Margin and operating leverage improved following the Kyber Data Science acquisition, with management reaffi...The Motley Fool
Wed, Aug 13
Cisco Systems Inc reports results for the quarter ended July 31 - Earnings Summary
Cisco Systems Inc CSCO.OQ reported quarterly adjusted earnings of 99 cents per share for the quarter ended July 31, higher than the same quarter last year, when the company reported EPS of 87 cents. The mean expectation of fifteen analysts for the quarter was for earnings of 98 cents per share. W...Reuters
Wed, Aug 13
Coherent Posts 16% Revenue Gain in Q4
Key Pointssurpassing the $0.92 non-GAAP analyst estimate for Q4 FY2025.GAAP revenue increased 16.4% year over year to $1.53 billion in Q4 FY2025, beating expectations on non-GAAP EPS.Networking segment revenue climbed 39% year-over-year in Q4 FY2025 (GAAP).These 10 stocks could mint the next wave of...The Motley Fool
Wed, Aug 13
Oncology Institute Inc reports results for the quarter ended June 30 - Earnings Summary
Oncology Institute Inc TOI.OQ reported a quarterly adjusted loss of 15 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -17 cents. The lone analyst forecast for the quarter was for a loss of 13 cents per share. Revenue rose 21...Reuters
Wed, Aug 13
Linamar Corp reports results for the quarter ended June 30 - Earnings Summary
Linamar Corp LNR.TO reported quarterly adjusted earnings of C$2.81 per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of C$3.06. The mean expectation of five analysts for the quarter was for earnings of C$2.75 per share. Wall Street expec...Reuters
Wed, Aug 13
